Sagespring Wealth Partners LLC Makes New $913,000 Investment in Danaher Co. (NYSE:DHR)

Sagespring Wealth Partners LLC acquired a new stake in Danaher Co. (NYSE:DHR) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 3,979 shares of the conglomerate’s stock, valued at approximately $913,000.

A number of other institutional investors have also made changes to their positions in DHR. Fortis Capital Advisors LLC increased its stake in Danaher by 1.3% in the 4th quarter. Fortis Capital Advisors LLC now owns 3,983 shares of the conglomerate’s stock valued at $914,000 after buying an additional 50 shares during the last quarter. Rockefeller Capital Management L.P. increased its position in shares of Danaher by 3.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 443,422 shares of the conglomerate’s stock valued at $101,801,000 after acquiring an additional 12,834 shares during the last quarter. NFP Retirement Inc. increased its position in shares of Danaher by 22.5% in the fourth quarter. NFP Retirement Inc. now owns 938 shares of the conglomerate’s stock valued at $215,000 after acquiring an additional 172 shares during the last quarter. Heritage Trust Co bought a new stake in Danaher during the fourth quarter worth about $6,840,000. Finally, Treasurer of the State of North Carolina boosted its position in Danaher by 0.9% during the fourth quarter. Treasurer of the State of North Carolina now owns 338,636 shares of the conglomerate’s stock valued at $77,734,000 after purchasing an additional 3,038 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 4.4 %

DHR opened at $188.75 on Monday. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock has a fifty day moving average of $203.71 and a 200-day moving average of $229.58. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The company has a market capitalization of $134.90 billion, a P/E ratio of 35.75, a P/E/G ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period in the previous year, the business posted $2.09 earnings per share. On average, equities analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.68%. The ex-dividend date is Friday, March 28th. This is a positive change from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is 24.24%.

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.10% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of a number of analyst reports. Barclays upgraded Danaher from an “equal weight” rating to an “overweight” rating and dropped their price objective for the stock from $240.00 to $205.00 in a research note on Thursday. Jefferies Financial Group dropped their price target on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research report on Wednesday, January 29th. Raymond James reissued a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. The Goldman Sachs Group raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $260.00 target price on the stock in a report on Friday, March 21st. Finally, Robert W. Baird lowered their price target on Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Four research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $276.57.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.